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The electrospinning technique provides non-wovens to the order of few nanometers with large surface
areas, ease of functionalisation for various purposes and superior mechanical properties. Also, the
possibility of large scale productions combined with the simplicity of the process makes this technique
very attractive for many different applications. Biomedical ﬁeld is one of the important application areas
among others utilising the technique of electrospinning like ﬁltration and protective material, electrical
and optical applications, sensors, nanoﬁber reinforced composites etc. Electrospinning assembly can be
modiﬁed in different ways for combining materials properties with different morphological structures
for these applications. The importance of electrospinning, in general, for biomedical applications like
tissue engineering drug release, wound dressing, enzyme immobilization etc. is highlighted in this
feature article. The focus is also on the types of materials that have been electrospun and the modiﬁ-
cations that have been carried out in conventional electrospinning apparatus keeping in view the speciﬁc
needs for various biomedical applications.
 2008 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction very attractive for many different applications. Biomedical ﬁeld isThe combined use of two techniques namely electrospray and
spinning is made use in a highly versatile technique called elec-
trospinning (electroþ spinning). A high electric ﬁeld is applied to
the droplet of a ﬂuid which may be a melt or solution coming out
from the tip of a die, which acts as one of the electrodes. This leads
to the droplet deformation and ﬁnally to the ejection of a charged
jet from the tip of the cone accelerating towards the counter
electrode leading to the formation of continuous ﬁbers. There is an
ever increasing interest in this ﬁeld of electrospinning shown by
both researchers in the academic institutions and industries as
evident from the increased number of publications and review
articles every year. Some of the review articles mentioning the
fundamentals of electrospinning, its historical development,
modiﬁed electrospinning techniques and their application areas are
recently published by us and others [1,2]. In fact, Polymer Inter-
national volume 56 (11), 2007 has a sequence of IN FOCUS mini
review articles about different aspects of electrospinning. The
important advantages of electrospinning technique are the
production of very thin ﬁbers to the order of few nanometers with
large surface areas, ease of functionalisation for various purposes,
superior mechanical properties and ease of process as suggested by
many experts in this ﬁeld. The possibility of large scale productions
combined with the simplicity of the process makes this technique(S. Agarwal), greiner@staff.
-NC-ND license.one of the important application areas among others utilising the
technique of electrospinning like ﬁltration and protective material,
electrical and optical applications, sensors, nanoﬁber reinforced
composites etc. There are some speciﬁc review articles on this
subject also [3]. Laurencin et al. have reviewed recently the patents
on eletrospun biomedical nanostructures [4]. The current available
techniques for nanoﬁber synthesis and the use of nanoﬁbers in
tissue engineering and drug-delivery applications are reviewed by
Vasita et al. [5]. A brief overview about electrospinning approaches
towards scaffold engineering is given by us [6].
Here we would like to highlight the importance of electro-
spinning, in general, for biomedical applications like tissue engi-
neering, drug release, wound dressing, enzyme immobilization etc.
We make no attempt to give a complete collection of related
literature but provide a progress in the ﬁeld of electrospinning for
biomedical applications including electrospinning of man-made
synthetic, natural and blend of synthetic and natural polymers,
chemically modiﬁed and designed polymers and modiﬁed elec-
trospinning techniques suitable for biomedical applications.2. Tissue engineering applications
Tissue engineering, also called regenerative medicine is an
interdisciplinary ﬁeld involving knowledge frommedicine, biology,
engineering and materials science ﬁelds. Tissue engineering makes
use of scaffolds to provide support for cells to regenerate new extra
cellular matrix which has been destroyed by disease, injury or
congenital defects without stimulating any immune response.
Fig. 1. Scaffold architecture affects cell binding and spreading [7].
S. Agarwal et al. / Polymer 49 (2008) 5603–56215604Natural extra cellular matrix (ECM) separates different tissues,
forms a supportivemeshwork around cells, and provides anchorage
to the cells. It is made up of proteins and glycosaminoglycans
(GAGs) which are carbohydrate polymers.
Electrospinning generates loosely connected 3D porous mats
with high porosity and high surface area which can mimic extra
cellular matrix structure and therefore makes itself an excellent
candidate for use in tissue engineering. The requirements for
a material to be used for tissue engineering purposes are biocom-
patibility, and biodegradability, as the scaffold should degrade with
time and be replaced with newly regenerated tissues. Also, the
scaffold architecture is very important and affects cell binding
(Fig. 1) [7]. The cells binding to scaffolds with microscale architec-
tures ﬂatten and spread as if cultured on ﬂat surfaces. The scaffoldsO
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Fig. 2. Chemical structures of some of the synthetic pwith nanoscale architectures have bigger surface area for absorbing
proteins andpresentmorebinding sites to cellmembrane receptors.
The adsorbed proteins further can change the conformations,
exposing additional binding sites, expected to provide an edge over
microscale architectures for tissue generation applications.
The use of electrospinning in the ﬁeld of tissue engineering till
date is mainly concentrated towards the following:
1. Formation of non-woven mats of different biomaterials to
biomimic physical dimensions of native ECMs, i.e. geometry
and morphology with nanodimensions. Proper choice of
biomaterials is required in terms of mechanical properties and
degradation time which depends upon the type of scaffold
required, type of the tissues to be regenerated and their
regeneration time. This includes electrospinning of known and
commercially available synthetic and natural biomaterials like
polylactide (PLA), polycaprolactone (PCL), poly(glycolic acid)
(PGA), and their copolymers etc. and especially synthesised
novel biomaterials that are designed to direct the organization,
growth, and differentiation of cells in the process of forming
functional tissues.
2. Modiﬁcation of the electrospinning process for the mimicking
of extra cellular matrix providing enhanced proliferation and
differentiation of cells.3. Formation of non-woven mats for biomedical applications
Various synthetic biopolymers have been electrospun to satisfy
different clinical requirements. Chemical structures of some of the
representative synthetic polymers electrospun are shown in Fig. 2.
Poly(a-hydroxy acids), especially lactic acids, glycolic acids and
their copolymers with 3-caprolactone, are the most commonly
known and used among all biodegradable polymers for fabrication)
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Fig. 3. (A) Melt electrospinning setup [9]. (B) Technical electrospinning setup with large scale width (A) and technical textile sheets coated by continous electrospinning. Photos
TransMIT Marburg (www.transmit.de).
Table 1
Cell studies on electrospun ﬁbers made of man-made materials
Electrospun polymer ﬁbers Cells or scaffolds Reference
Poly(lactide) PLA Endothelial [15]
Human osteosarcoma MG-63
cells
[16]
Poly(lactide-co-glycolide) PLA–PGA C17.2 nerve stem cells [17]
Polyurethane (PU) Smooth muscle cells [18]
Modiﬁed polyethyleneimine (PEI) Normal human ﬁbroblast
(NHF)
[19]
Poly(propylene carbonate),
poly(cyclohexyl carbonate)
L929 ﬁbroblasts, primary rat
hepatocytes
[20]
Poly(propylene carbonate) Bone marrow mesenchymal
stem cells (MSCs)
[21]
Silicate Human osteoblastic MG63
cells
[24]
Polyphosphazenes Endothelial cells [25]
Plasma modiﬁed and acrylic
acid grafted PGA, PLA and PLGA
Fibroblasts [27]
Polyester urethane Fibroblasts [28]
Poly(L-lactide)–hydroxyapatite
composite (PLLA/HA)
Osteoblast cell MG-63 [29]
Poly(L-lactide)–multiwalled carbon nano
tubes–hydroxyapatite
(polyPLLA/MWNTs/HA)
Periodontal ligament cells [30]
Poly(lactide-co-glycolide) (PLGA)/
amorphous tricalcium phosphate
Human mesenchymal stem
cells
[31]
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applications. Piskin et al. [8] have reviewed the electrospinning
process of these polymers and give selected recent applications of
electrospun matrices made from these polymers. They degrade in
vivo into nontoxic end products mainly by hydrolysis in a few
weeks to several months, depending on molecular structure/
morphology, average molecular weight etc. Also, melt electro-
spinning of different polymers like poly(lactide) [9] (Fig. 3A),
poly(ethyleneglycol-caprolactone) [10] is known to generate sub-
micron scaleﬁbers. This solvent-free approach toproduce sub-micron
scale ﬁbers is more advantageous in terms of environmentally
benign process than common solution electrospinning processes,
and has a potential to increase the production rate signiﬁcantly.
Technical scale electrospinning of biodegradable polymers is also
available now-a-days using specially designed electrospinning
setup (Fig. 3B).
Ashammakhi et al. [11] and Teo et al. [12] have brieﬂy over-
viewed the formation of biodegradable nanomats by electro-
spinning and their potential use for tissue engineering applications.
Chew et al. [13] have reviewed the analysis and control of elec-
trospinning process, and describes the types of ﬁbers fabricated for
biomedical applications such as drug delivery, tissue engineering.
Most recently a review article providing insight to the generation of
smart scaffolds by different technologies including electrospinning
is given by Moroni et al. [14A]. An overview about functional
electrospun nanoﬁbrous scaffolds for biomedical applications is
provided by Chu et al. [14B]. It is evident from this vast literature
that electrospinning of any biodegradable and biocompatible
polymer is no more a problem. By adjusting electrospinning
conditions like voltage, distance between the electrodes, ﬂow rate
of solution during electrospinning and polymer solution properties
like viscosity, conductivity etc. any polymer can be electrospun.
Further to mimic ECM and to propose electrospun biodegrad-
able mats for any tissue engineering application, various research
groups have studied growth of different kinds of cells (Table 1). In
a study by Ramakrishna et al., human vascular endothelial cells
cultured on smooth solvent-cast PLA surface were shown to bemore than on the rough electrospun surface [15]. On contrary,
Boudriot et al. [16] have shown the preference of human osteo-
sarcoma MG-63 cells growth on electrospun poly(L-lactide) nano-
structured scaffold (average ﬁber diameter between 200 nm and
5 mm; electrospun from dichloromethane with microporous
surface structure) along the nanoﬁbers covering them, and showed
no sign of degeneration or apoptosis. Bini et al. [17] have shown the
growth of C17.2 nerve stem cells on poly(lactide-co-glycolide)
(PLGA) nanomats, microbraided and aligned microﬁber scaffolds.
They also showed attachment and differentiation of these cells
along the direction of the ﬁbers.
Fig. 4. Electrospun PPC grafts under stereoscopic microscope: (a) Lateral view and (b) transverse view [21].
S. Agarwal et al. / Polymer 49 (2008) 5603–56215606PU is a biodegradable material which degrades by hydrolysis
and enzyme based chain cleavage and has been used by Rockwood
et al. [18] for use as a temporary scaffold in tissue engineering. The
phase segregated morphology of the polyurethane imparts elas-
tomeric properties that are attractive for soft tissue engineering.
Non-woven mats of polyethyleneimine (PEI) cross-linked with
succinic anhydride and 1,4-butanediol diglycidyl ether were evalu-
ated as interaction scaffolds for normal human ﬁbroblast (NHF)
cells [19]. Non-woven mats of PEI in the range 1600–687 nm were
evaluated as interaction scaffolds for normal human ﬁbroblast cells.
Cell viability was evaluated by staining with propidium iodide for
dead cells and ﬂuorescein diacetate for live cells. Fluorescence
studies conﬁrmed that NHF cells were attached and spread
throughout the cross-linked linear polyethyleneimine scaffold. The
attachment and spreading of cells suggests that electrospun linear
polyethyleneimine scaffolds support growth of normal human
ﬁbroblasts cells.
Aliphatic polycarbonates like poly(propylene carbonate) (PPC)
and poly(cyclohexyl carbonate) were also electrospun with an
intend to be utilized for tissue engineering [20]. They were used for
cell culture of L929 ﬁbroblasts and primary rat hepatocytes. The
cells showed good adhesion to the scaffolds and high viability.
Tissue engineering of vascular grafts with genetically modiﬁed
bone marrow mesenchymal stem cells (MSCs) on poly(propylene
carbonate) graft is studied by Zhang et al. [21]. The MSCs were
seeded onto the electrospun ﬁbrous grafts and cultured. The
authors showed the integration of seeded cells with the microﬁber
of the scaffold to form a three-dimensional cellular network, indi-
cating a favourable interaction between the synthetic PPC scaffolds
with MSCs. The use of MSCs and therapeutic genes in tissue engi-
neering of blood vessels could be helpful in improving regenera-
tion. A tubular scaffold (2 mm in diameter) with a microstructure of
non-woven ﬁbers was produced by electrospinning of poly(propylene
carbonate) (Fig. 4). A recent feature article by Bowlin et al. [22]
highlights the importance of electrospinning for vascular grafts.
According to the authors the laboratory research performed on
electrospun bioresorbable vascular prosthetics has proven the
potential to be transferred to clinical use in the future. Electro-
spinning offers the ability to use a wide range of polymers, thereby
allowing control over graft’s mechanical and bioactive properties
that can closely mimic the behaviour of a native artery.
Electrospun mats of tyrosine-derived polycarbonate ﬁbers are
provided byMeechaisue et al. for potential use as tissue scaffolding
material [23]. The modiﬁed polycarbonates were produced fromO O O O O O O
R
O
O O
R
Fig. 5. Chemical structures oDesaminotyrosyl-tyrosin ethyl ester and desaminotyrosyl-tyrosine
monomers to tune the degradability rates. Silicate ﬁbers prepared
via electrospinning and sol–gel process were evaluated as scaffolds
for bone tissue engineering by Sakai et al. [24]. They found that
human osteoblastic MG63 cells successfully adhered on individual
silicate ﬁbers, and proliferated on them. Carampin et al. showed
[25] the use of biocompatible polyphosphazenes (i.e. poly(aminoacid
alkyl ester) phosphazenes) to construct human tissues such as
vessels or cardiac valves. The ﬂat or tubular matrices from poly(ethyl
phenylalanato)1.4(ethyl glycinato)0.6phosphazene by electrospinning
was evaluated for the growth of rat neuromicrovascular endothelial
cells cultured on sheets and tubes with an average ﬁber diameter of
850150 nm. Microscopic examination of the seeded tubes
showed the formation of monolayer of endothelial cells after 16
days incubation.
4. Electrospinning of modiﬁed degradable polymers
Further, modiﬁed biodegradable polymers were electrospun in
order to either improve cell proliferation or growth on the scaffolds
or for modifying the biodegradability rate or mechanical properties
of the scaffolds. To improve the hydrophilicity, liability, and
degradability of biodegradable polymer like PLA, a triblock copoly-
mer of PEG and lactide (PLA–PEG–PLA) is made and electrospun
into ﬁbrous membranes in the ﬁber sizes 7.5 mm–250 nm [26].
Surface modiﬁcation of biodegradable electrospun nanoﬁber scaf-
folds and their interaction with ﬁbroblasts is studied by Park et al.
[27]. The surfaces of electrospun PGA, PLA and PLGA nanoﬁbers
were chemically modiﬁed using oxygen plasma treatment and in
situ grafting of hydrophilic acrylic acid (AA). The ﬁber thickness,
pore size and porosity were estimated to be 200–800 nm, 2–30
micron and 94–96 %, respectively. Fibroblasts once seeded on the
scaffolds were spreading over large surface area on the AA-grafted
surface as compared to the unmodiﬁed PGA, PLA and PGLA nano-
ﬁbrous scaffolds. Another modiﬁcation of polyesters, i.e. polyester
urethane (Fig. 5) with slowed degradation was electrospun and
tested for ﬁbroblasts viability and suggested as potential biode-
gradable and biocompatible material for tissue engineering by
Jerome et al. [28].
Naturally, bones are generally strengthened by the nucleation of
hydroxyapatite (HA) into nano sized gaps between collagen mole-
cules. In order tomimic and to have strengthened scaffolds for bone
tissue engineering, PLA/hydroxyapatite (HA) hybrid membranes
were fabricated by electrospinning of PLA/HA dispersion [29A,29B].O O
O
N
H
H
N
O
O
f the polyesterurethane.
Table 2
Mechanical properties of PLLA and PLLA/HA hybrid membrane
Sample Thickness (mm) Modulus (MPa) Ultimate
strength (MPa)
Ultimate
strain (%)
PLLA 0.040 0.005 12 2 1.40 0.11 90.0 6
PLLA/HA 0.0406 0.005 118 10 2.86 0.24 5.6 0.5
Table 3
Cell studies on electrospun ﬁbers made of bio-based polymers and mixtures with
man-made materials
Electrospun ﬁbers Proposed biomedical use Reference
Cellulose acetate (CA) Urinary bladder matrix [36]
Chitosan and derivatives Antibacterial material [38–40]
Silk ﬁbroin (SF) Tissue engineering (Growth of
keratinocytes and ﬁbroblasts)
[3]
B. mori silk ﬁbroin Vascular grafts (Tubular scaffolds)
(growth of human endothelial cells
and smooth muscle cells)
[41]
Fibrinogen Tissue engineering (Growth of
neonatal rat cardiac ﬁbroblasts)
[42]
Alginate Tissue engineering [43]
Collagen Tissue Engineering [44–48]
Aortic smooth muscle cells
Blend of polyaniline/gelatin Vascular grafts (Growth of H9C2 rat
cardiac myoblast cells)
[51]
Blends of collagen, elastin with
biodegradable polymers
Soft tissue engineering (Heart, lung
and blood vessels) (Growth of H9c2
cardiac myoblasts and bone marrow
stromal cells (BMSCs)
[52,53]
Composite of gelatine/
hydroxyapatite (HA)
Osteoblast MG63 [54]
Blends of collagen/
poly(caprolactone) PCL
Artiﬁcial implant [55,117]
Schwann cell growth, dermal
ﬁbroblast cells
Blends of chitosan/
polycaprolactone (PCL)/
poly(vinyl alcohol) PVA
Tissue engineering [56]
Mesenchymal stem cells
Blends of PLGA/chitosan/PVA Tissue engineering [57]
Blend of collagen/poly(3-
hydroxybutyrate-co-3-
hydroxyvalerate) PHBV
Scaffolds [58]
NH3T3 cells
Plasma treated and grafted
polycaprolactone (PCL) by
collagen
Tissue engineering [59]
Collagen/PCL/tricalcium
phosphate
Orecurson based
osteochondral repair
[60]
S. Agarwal et al. / Polymer 49 (2008) 5603–5621 5607The osteoblast cell (MG-63) was cultured in PLLA/HA hybrid
membrane. The cell adhesion and growth capability were investi-
gated by SEM observation and MTT assay. HA nanoparticles were
not only dispersed in PLLA but also reacted with the functional
group of PLLA, resulting in strong surface bonding and high tensile
strength of hybrid membrane (Table 2). The cell adhesion and
growth on the PLLA/HA hybrid membrane were far better than
those on the pure PLLA membrane, which proves that the PLLA/HA
hybrid membrane can be one of the promising biomaterials for
bone tissue regeneration.
However, in order to produce electrospun ﬁbers with homo-
genous structure, it is essential for the ceramic powder to be ﬁne
and to remain stable in suspension. Kim et al. [29C] have provided
a modiﬁed method of making nanocomposite of PLA/HA by elec-
trospinning. They have introduced a surfactant hydroxyl stearic
acid between hydrophilic HA powder and hydrophobic PLA in
a chloroform solution.
A new type of guided tissue regeneration (GTR) membrane is
developed by Mei et al. [30] by electrospinning a suspension con-
sisting of poly(L-lactic acid), multiwalled carbon nanotubes, and
hydroxyapatite (PLLA/MWNTs/HA). Authors have shown the
enhanced adhesion and proliferation of periodontal ligament cells
(PDCLs) by 30%. After PDCL cells were seeded onto the electrospun
membranes, cell/membrane composites were implanted into the
leg muscle pouches of immune deﬁcient mice and functioned well
in vivo. Authors are of the opinion that compared to other GTR
membranes on sale or research, this system can simplify the
manufacturing process, reduce the fabrication cost and avoid
possible mistakes in clinical applications. Schneider et al. [31] have
evaluated the in vitro biomedical performance of an electrospun
poly(lactide-co-glycolide) (PLGA)/amorphous tricalcium phosphate
(ATCP) nanocomposites. Experiments on in vitro biomineralization,
applicability in model defects and a cell culture study with human
mesenchymal stem cells (hMSC) allowed assessing the application
of the material for potential use as a bone graft. A novel kind of
poly(butylene succinate) (PBSU)/wollastonite/apatite composite
scaffold was fabricated by electrospinning by Zhang et al. [32] for
bone tissue engineering. Wollastonite (b-CaSiO3) nanowires were
ﬁrst prepared by a hydrothermal route and then surface modiﬁed
using dodecyl alcohol to enhance the dispersion of Wollastonite
and promote the interfacial adhesionwith PBSU. SEM and XRD data
showed the deposition of apatite on the surface of composite ﬁbers
and the microstructure of the scaffolds could be controlled by the
amount of Wollastonite content and the incubation time.
Layer-by-layer electrospinning (LBL) was shown ﬁrst by Kidoaki
et al. [33]. In LBL electrospinning, each polymer solution is elec-
trospun to form its individual layer and is collected on the same
target collector. A new type of guided bone regeneration (GBR)
membrane was fabricated by polycaprolactone (PCL)/CaCO3
composite nanoﬁbers using layer-by-layer electrospinning method
[34]. In order to achieve mechanical stability of GBR membranes,
composite nanoﬁbers were spun on PCL nanoﬁbrous membranes
which has high tensile strength, i.e. the membranes consist of two
layers of functional layer (PCL/CaCO3) andmechanical support layer
(PCL). Also, Layman et al. [35] have utilized LBL electrospinning for
the development of the biohemostat, a treatment for high pressure
bleeding based on super-absorbent polymers and electrospun
membranes.5. Electrospinning of natural polymers
Electrospinning method has been utilized to generate non-
woven mats for tissue engineering using different natural
biopolymers including proteins (gelatine, collagen and silk ﬁbrin-
ogen) and polysaccharides (chitosan, hyaluronic acid and cellulose)
(Table 3). These materials have their own advantages and disad-
vantages for biomedical applications. On one side unlike synthetic
biomaterials, these natural polymers provide many of the instruc-
tive cues required by the cells attachment and proliferation and on
the other side have the problem of batch-to-batch property varia-
tion. Cellulose acetate (CA) (Fig. 6) is a biomaterial of choice for
building the urinary bladdermatrix (UBM)mimicking scaffolds and
its electrospinning for this purpose is shown by Han et al. [36].
Ohkawa et al. showed the electrospinning of natural polymer
chitosan [37] (N-deacetylated derivative of chitin), a natural
cationic polysaccharide having hydroxyl and amino groups regu-
larly arranged at the equatorial positions in the b(1,4)-linked
D-glucosamine repeating units. It is environmentally friendly,
nontoxic, biodegradable and antibacterial. Water-insoluble chito-
san nanoﬁber sheets and tubes are prepared by Matsuda et al. and
28% ammonium aqueous solution is used for bringing water
insolubility [38]. Schiffman et al. [39] have provided Schiff base
cross-linked chitosan mats using a one-step electrospinning
process that is claimed to be 25 times faster and, therefore, more
economical than a previously reported two-step vapour-cross-
linking method. Combination of synthetic and natural polymers
could combine the advantage of easy properties modiﬁcation of
synthetic polymers with biofunctionalities of natural polymers.
Fig. 6. Chemical structures of some natural polymers.
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CL) blends were electrospun into nanoﬁbers using 1,1,1,3,3,3-hexa-
ﬂuoro-2-propanol (HFIP) and triﬂuoroacetic acid (TFA) as solvents
by Chen et al. [40]. Chitosan, which is otherwise difﬁcult to elec-
trospin into nanoﬁbers, could be easily electrospun into nanoﬁbers
with addition of a small portion of P(LLA–CL). The ﬁber diameter
depended on both the polymer concentration and the blend ratio of
chitosan to P(LLA–CL). The average ﬁber diameter increased with
increasing polymer concentration and decreasing the blend ratio of
chitosan to P(LLA–CL). The porosity of CS/P(LLA–CL) nanoﬁber mats
increased with increasing the weight ratio of chitosan to P(LLA–CL),
while both the tensile strength and the ultimate strain increased
with increasing P(LLA–CL) ratio. Fibroblast cell growth on nanoﬁber
mats was investigated with MTT assay and scanning electron
microscope (SEM) observation. The highest cell proliferation was
observed on the nanoﬁber mats when the weight ratio of chitosan
to P(LLA–CL) was 1:2.
Min et al. [3] have electrospun regenerated silk ﬁbroin (SF) in
formic acid. Fibroin consists of approximately 42% glycine and 25%
alanine as the major amino acids. The remaining components are
mostly glutamine, serine, leucine, valine, proline, tyrosine and
arginine. To assay the cytocompatibility and cell behaviour onto
the elctrospun SF nanoﬁbers, cell attachment and spreading of
normal human keratinocytes and ﬁbroblasts were seeded and the
results indicated SF to be a good candidate for tissue engineering
scaffolds. Electrospinning was also used to fabricate non-wovennanoﬁbrous tubular scaffolds from Bombyx mori silk ﬁbroin using
an all aqueous process [41]. Cell studies and mechanical charac-
terization tests were performed on the electrospun silk tubes to
assess the viability of their usage in bioengineering small-dia-
meter vascular grafts. Human endothelial cells and smooth muscle
cells were successfully cultured on the electrospun silk. Mechan-
ical characterization tests demonstrated burst strength sufﬁcient
to withstand arterial pressures and tensile properties comparable
to native vessels. These cellular and mechanic outcomes demon-
strate potential utility of these electrospun silk scaffolds for small-
diameter vascular grafts.
McManus et al. [42] have demonstrated based on cellular
interaction (neonatal rat cardiac ﬁbroblasts) and scaffold remod-
elling that electrospun ﬁbrinogen can be used successfully as
a tissue engineering scaffold. Zhang et al. [43] have fabricated
alginate based nanoﬁbers and also investigated many issues related
to the spinnability and reproducibility. Alginate is a biodegradable
polymer derived from sea weed. It is a linear polysaccharide
copolymer consisting of two sterically different repeating units,
(1,4)-a-L-guluronate (G unit) and (1,4)-b-D-mannuronate (M unit)
in different proportions (Fig. 6) . In the initial stage, the gelation of
alginate solution at very low polymer concentrations (e.g. around
2 wt% for alginate in water) made electrospinning difﬁcult. Their
study showed that polymer solution viscosity is the key factor that
regulates the spinnability and structure of electrospun product.
Solution viscosity can be changed in a number of ways including
Fig. 7. Fluorescence graphs of conﬂuent H9C2 myoblast cells on (A) PLGA (B) PLGA–gelatin–elastin (PGE) [53].
S. Agarwal et al. / Polymer 49 (2008) 5603–5621 5609addition of a second hydrophilic polymer and/or surfactants or
alternation of polymer molecular weight. The sustained structural
integrity of nanoﬁbers in aqueous environment as well as simu-
lated blood ﬂuid, which is essential for tissue engineering
applications, was improved by cross-linking using CaCl2, epichlo-
rohydrin, gluteraldehyde, hexamethylenediisocyanate and adipic
acid hydrazide.
Many authors have reported the electrospinning of one of the
most commonly used proteins, i.e. collagen, a natural component of
ECM in solvents like 1,1,1,3,3,3-hexaﬂuoro-2-propanol and showed
cell growth and proliferation both in vivo and in vitro [44–46]. Very
recently Zeugolis et al. [47] showed for the ﬁrst time that the very
properties of collagen that established it as natural biomaterial are
lost when it is electrospun from 1,1,1,3,3,3-hexaﬂuoro-2-propanol
or 2,2,2-triﬂuoroethanol. These solvents led to denaturation of
collagen and the resulting electrospun scaffolds lack the unique
ultra-structural axial periodicity that conﬁrms quarter-staggered
supramolecular assemblies and the capacity to generate second
harmonic signals. Yang et al. [48] have also reported the denatur-
ation of collagen Type I ﬁbers electrospun from 1,1,3,3,3-hexa-
ﬂuoro-2-propanol.
Since natural polymers like chitosan, gelatine etc. have limited
solubility in water, toxic and highly acidic solvents like 1,1,1,3,3,3-
hexaﬂuoro-2-propanol and triﬂuoroacetic acid are used for their
electrospinning, Song et al. [49] electrospun gelatine from a newly
developed water-based co-solvent composed of ethyl acetate and
acetic acid in water. The optimal composition of the co-solvent was
found to correspond to a ratio of ethyl acetate to acetic acid of 2:3.
Under this solvent condition, the gelatine could be dissolved at
concentrations of upto w11 wt% and produced ﬁbers in the diam-
eter range 47–145 nm.Fig. 8. Schematic illustration of the process used to produce the gelatin–HA nanocomposi
dissolved in an organic solvent HFP (c) for the electrospinning process. The electrospinni
pyl]carbodiimide hydrochloride/NHS) (N-hydroxysuccinimide) [54].Comparitive electrospinning behaviour of different proteins like
collagen, gelatine (denatured collagen), solubilised a-elastin and
recombinant human tropoelastin is given by Li et al. [50]. Also,
a blend of polyaniline, a conductive polymer with a natural protein,
gelatine, was electrospun by Li et al. [51] to investigate the potential
of such a blend as conductive scaffold for tissue engineering
purposes. The blend ﬁbers supported the growth of H9C2 rat
cardiac myoblast cells. Due to diversity in size, mechanical and
biochemical properties, cellular content and ultra-structural orga-
nization of blood vessels, it is required to control the fabrication of
vascular grafts for obtaining desirable characteristics of blood
vessel substitutes. Lee et al. [52] have fabricated various scaffolds
with blends of collagen, elastin and several biodegradable polymers
using electrospinning. Materials were blended at a relative
concentration by weight of 45% collagen, 15% elastin, and 40%
synthetic polymer to mimic the ratio of collagen and elastin in
native blood vessels. The introduction of synthetic biodegradable
polymers enabled tailoring of mechanical properties of vascular
substitutes and improving compliance matching for vascular tissue
engineering. Also, Li et al. [53] have studied composite scaffolds
composed of natural materials (gelatin and elastin) and synthetic
polymer (PLGA). The resulting PLGA–gelatin–elastin (PGE) ﬁbers
were homogenous with an average diameter of 380 80 nm.
Cultured H9C2 rat cardiac myoblasts grew slightly better on the
scaffolds (Fig. 7) and are proposed for engineering soft tissues, such
as heart, lung and blood vessels.
Nanoﬁbers of gelatine-hydroxyapatite mimicking human bone
matrix were also generated for guided tissue engineering by Kim
et al. [54]. The HA precipitate/gelatine matrix are lyophilized and
dissolved in an organic solvent, and then electrospun (Fig. 8). These
nanocomposites are shown to have improved bone-derived cellularte ﬁber. The HA precipitate/gelatin matrix nanocomposite (a) was lyophilized (b) and
ng ﬁbers were subsequently cross-linked with EDC (1-ethyl-3-[3-dimethylaminopro-
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biocompatibility of the nanocomposite ﬁbers was assessed by
measuring their bone-derived cell (MG63) responses.
Guidance of cell migration and axonal growth on electrospun
nanoﬁbers of PCL and Collagen/PCL blend was studied by Schnell
et al. [55] with an aim to develop an artiﬁcial implant as a conduit
for axonal regeneration after peripheral nerve injury. Schwann cell
migration, neurite orientation, and process formation of Schwann
cell, ﬁbroblasts cells were improved on collagen/PCL ﬁbers, when
compared to pure PCL and showed this to be a good material for
artiﬁcial nerve implants.
3D nanoﬁbrous hybrid scaffolds consisting of PCL, poly(vinyl
alcohol) (PVA) and chitosan were prepared via a multijet electro-
spinning method [56]. The inﬂuence of chemical, physical, and
structural properties of the scaffolds on the differentiation of
mesenchymal stem cells into osteoblasts, and the proliferation of
the differentiated cells were investigated. Similarly, Duan et al. [57]
have studied electrospun PLGA–chitosan/PVA membranes and
their cytocompatibility in vitro. They havemade hybridmembranes
by simultaneous electrospinning of PLGA and chitosan/PVA from
two different syringes. The ﬁbrous composite membranes were
investigated as a promising scaffold for human embryo skin ﬁbro-
blast culture. The introduction of chitosan/PVA changed the
hydrophilic/hydrophobic balance and, thus inﬂuenced the
mechanical properties, degradation behaviour and cell prolifera-
tion and attachment to the membranes. Also, Meng et al. [58]
studied biodegradable hybrids of poly(3-hydroxybutyrate-co-3-
hydroxyvalerate)(PHBV) and type I collagen in 1,1,1,3,3,3-hexa-
ﬂuoro-2-isopropanol (HIFP) as nanoﬁbrous (300–600 nm)
scaffolds. The cell culture experiments indicated an accelerated
adhesion and growth of NH3T3 cells on hybrid scaffolds instead of
PHBV scaffolds. In another study, non-woven PCL nanoﬁbers were
prepared by electrospinning and type I collagen was then immo-
bilised on the nanoﬁbers after surface modiﬁcation by remote
plasma treatment [59] to be a potential scaffold material for tissue
engineering. Schumann et al. [60] have combined electrospinning
with fused deposition modelling (FDM), to produce bioactive poly-
(caprolactone)/collagen type I and type II PCL-tricalcium phosphate
composites for orecurson cell based osteochondral repair. The
application of these two design techniques (electrospinning and
FDM) speciﬁcally produced a suitable three-dimensional (3D)
environment for the cells to grow into a particular tissue (bone and
cartilage) in vitro prior to in vivo implantation. Zhang et al. [61]
provides an overview on the current development and application
status of employing electrospun composite nanoﬁbers for con-
structing biomimetic and bioactive tissue scaffolds. Also, tubular
scaffold of marine source collagen and PLGA ﬁbers were fabricated
by Jeong et al. [62]. The hybrid scaffolds, composed of a porous
collagen matrix and a ﬁbrous PLGA layer, had an average pore size
of 150þ/50 mm. The electrospun PLGA layer on the surface of
a porous tubular collagen scaffold improved the mechanical
strength of the collagen scaffolds in both dry and wet states. A
signiﬁcant cell alignment in a directional radial to the distending
direction was observed in tissues exposed to radial distention,
which is similar to the phenomenon of native vessel tissues in vivo.
On the contrary, cells which were tissue engineered in the static
condition were randomly alligned.
6. Biofunctionalisation for biomedical applications
Mimicking ECM by electrospinning of various materials is now
easily possible. The efﬁciency of using the process for any useful
tissue engineering application will be further decided by bioactive
groups incorporated into artiﬁcial ECM structures. Incorporation of
bioactive agents into electrospun ﬁbers could lead to a biofunc-
tional tissue engineering scaffold and biofunctionalization ofelectrospun ﬁbers will determine the efﬁciency of these ﬁbers for
regenerating biological functional tissues. Bioactive agents could be
either incorporated via encapsulation or could be covalently
conjugated to the matrix polymer. Zhang et al. [61] have reviewed
composite nanoﬁbers for constructing biomimetic and bioactive
tissue scaffolds. ECM-derived scaffolds contain bioactive molecules
that exert in vivo mimicking effects as applied for soft tissue
engineering, yet do not possess the same ﬂexibility in mechanical
property control as some synthetics. Stankus et al. [63] tried to
combine the controllable properties of a synthetic, biodegradable
elastomer with the inherent bioactivity of an ECM-derived scaffold.
A hybrid electrospun scaffold composed of a biodegradable poly(ester
urethane)urea (PEUU) and a porcine ECM scaffold (urinary bladder
matrix, UBM) was fabricated and characterized for its bioactivity
and physical properties both in vitro and in vivo. Increasing
amounts of PEUU led to linear increase in both tensile strength and
breaking strain while UBM incorporation led to increased in vitro
smooth muscle cell adhesion and proliferation and in vitro mass
loss. Subcutaneous implantation of the hybrid scaffolds resulted in
increased scaffold degradation and a large cellular inﬁltrate when
compared with electrospun PEUU alone. Electrospun UBM/PEUU
combined the attractive bioactivity and mechanical features of its
individual components to result in scaffolds with considerable
potential for soft tissue engineering applications. Rabolt et al. [64]
fabricated poly(ethylene glycol) PEG functionalized with low
molecular weight heparin (PEG–LMWH) using electrospinning
technique for possible use in drug delivery, tissue engineering or
wound repairing applications. The incorporation of heparin into the
electrospun PEG and PLGA (poly(lactide-co-glycolide)) ﬁbers did
not affect the surface morphology or ﬁber diameters. Improve-
ments in the binding of basic ﬁbroblast growth factor to the
electrospun ﬁbers were also observed for ﬁbres functionalised
with PEG–LMWH. A brief overview on the development and
application of electrospun composite nanoﬁbers (blend composite
nanoﬁbers, core–shell structured and nanoﬁbrous mingled) for
constructing biomimetic and bioactive tissue scaffolds is written by
Zhang et al. [65].
Eletrospun natural polymer membranes were fabricated from
collagen or gelatine coated with a bioactive recombinant fragment
of perlecan, (PInDI) a natural heparin sulphate proteoglycan by
Rabolt et al. [66]. Glutaraldehyde was used as cross-linking agent. It
cross-links collagen and gelatin ﬁbers via the reaction between the
carboxyl groups on the glutaraldehyde and the amide groups of the
collagen or gelatin to form cross-links between polymer chains.
Laser scanning confocal microscopy revealed that osteoblast-like
MG63 cells inﬁltrated the depth of the electrospun membrane
evenly without visible apoptosis. PInDI coated electrospun collage
ﬁbers were 10 times more effective than heparin-BSA collagen
ﬁbers at binding growth factors.
A non-woven fabric made up of electrospun polyamide nano-
ﬁbers [67] supported axonal regeneration in injured rat spinal cord.
It was shown by the authors that covalent modiﬁcation of the
nanoﬁbers with a bioactive peptide derived from the neuro-
regulatory extra cellular matrix molecule tenascin-C enhanced the
ability of the nanoﬁbers to facilitate axonal growth.
Leong et al. [68] have investigated the encapsulation of protein
human b-nerve growth factor (NGF) in a copolymer of caprolactone
and ethyl ethylene phosphate by electrospinning (Scheme 1; Fig. 9).
The authors have taken a copolymer of PCL to ﬁne tune the
degradation rate of PCL by introducing more hydrophilic
poly(phosphoesters) in the polymer. Bioactivity of NGF was
retained partially for at least three months, thereby demonstrating
the feasibility of encapsulating proteins via electrospinning to
produce biofunctional tissue scaffolds. Continuous nanostructure
embedded with proteins present topographical and biochemical
signals to cells for tissue engineering applications.
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Scheme 1. Synthetic route to poly(caprolactone-co-ethyl ethylene phosphate) (PCLEEP) [68].
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nanoﬁbers by coaxial electrospinning [69]. This technique proved
to be very versatile for encapsulation of biorelevant molecules and
nanocomposites. Liao et al. [70] have shown coaxial electro-
spinning of aligned PCL nanoﬁbers encapsulated with bovine and
platelet-derived growth factor-bb for demonstration of controlled
release and bioactivity retention. Controllable release kinetics is
achieved by incorporation of PEG as a porogen in the shell of
nanoﬁbers. Zhang et al. [71] have also demonstrated the successful
encapsulation of a model protein, ﬂuorescein isothiocyanate-
conjugated bovine serum albumin (ﬁtcBSA), alongwith PEG, within
the biodegradable poly(caprolactone) PCL nanoﬁbers using
a coaxial electrospinning technique (Fig. 10). Simply, by varying the
inner ﬂow rate with a constant outer ﬂow rate, ﬁtcBSA loadings
could be varied. Composite nanoﬁber PCL/ﬁtcBSA/PEG blend was
prepared from normal electrospinning method, as a negative
control. The core-sheath nanoﬁbers compared to that of blend gave
better sustainability.
Living membranes containing biological moieties like bacterias,
viruses, cells etc. carrying speciﬁc functions, offer many unique
opportunities for materials and life sciences. Immobilization of
biological objects with intact functions in living membranes is of
considerable technical interest. Jaysinghe et al. [72,73] have
explored the possibility of using coaxial electrospinning technology
for the generation of scaffolds comprised of living organisms in the
form of threads and scaffolds. The method of coaxial electro-
spinning has also shown its advantage in depositing active bio-
logical threads and scaffolds. This has been achieved by use of
a coaxial needle arrangement where a concentrated living bio-
suspension ﬂows through the inner needle and a medical grade
poly(dimethylsiloxane) (PDMS) medium with high viscosity
(12 500 mPa s) and low electrical conductivity (10–15 Sm1) ﬂows
through the outer needle. First they demonstrated the process with
immortalized human brain astrocytoma (1321N1, European
collection of cell cultures) cell line at a cell concentration of 10(6)
cells/mL. Later, they employed primary porcine vascular and rabbit
aorta smooth muscle cells prepared as cellular suspensions at cell
concentrations of 10(7) cells/mLwhich seems to be the highest ever
cell concentration threaded by any threadingmethodology. The cellFig. 9. (a) Aligned BSA encapsulated PCLEEP ﬁbers electrospun at 1 mL/h. (b) Fluoresceinelectrospinning device uses a coaxial needle arrangement with the
ﬂow of highly concentrated cellular suspension in the inner needle
and medical grade polydimethylsiloxane in the outer needle. The
post-cell electrospun organisms are viable over long periods of
time. Collected cells that have been cultured, postelectrospinning,
have been found to be viable and show no evidence of having
incurred any cellular damage during the bionanofabrication
process (Fig. 11).
Bacteria and viruses [74] were also encapsulated in electrospun
polymer nanoﬁbers and were shown to survive electrospinning
process and remained viable for three months at lower tempera-
tures like 20 and 55 C. The bacteria (Escherichia coli, Staphylo-
coccus) and viruses (T7, T4, l) were suspended in a solution of
poly(vinyl alcohol) PVA inwater and subjected to electrostatic ﬁeld
of the order 1 kV cm1 for encapsulation [74A]. In our group we
have shown the survival of Micrococcus luteus, an airborne non-
pathogenic Gram-positive bacteria under elctrospinning conditions
[74B] (Fig. 12).
Also, dispersions of M13 viruses in water soluble poly-
vinylpyrrolidone PVP were processed to nanoﬁbers by electro-
spinning [74C]. Resulting virus-PVP electrospun ﬁbers maintained
their ability to infect bacterial hosts after resuspending in buffer
solution. These remarkable ﬁndings clearly showed that non-
wovens composed of polymer nanoﬁbers and complex biological
objects can be prepared directly without total loss of biological
functionality.
The effect of nanoﬁber surface coatings on the cell’s prolifera-
tion behaviour was studied by Zhang et al. [75]. Coaxial electro-
spinning technique was used for producing collagen coated
polycaprolactone (PCL) nanoﬁbers (Fig. 13). Coatings of collagen on
PCL were shown to favour proliferation of human dermal ﬁbro-
blasts and also encouraged cell migration inside the scaffolds. Using
a similar approach, biodegradable ﬁbrous scaffolds composed of
gelatine coated PCL were prepared by Zhao et al. by coaxial elec-
trospinning [76].
In order to mimic normal epithelial regeneration on synthetic
scaffold in vitro, biodegradable elastic poly(lactide-co-capro-
lactone) (PLLC) was processed into a nanoﬁbrous scaffold using
electrospinning technology [77]. An adhesive protein, ﬁbronectinisothiocyanate-conjugated bovine encapsulated electrospun ﬁbers of PCLEEP [68].
Fig. 10. (a) Schematic illustration of a coaxial electrospinning spinneret used in preparing PCL-r-ﬁtcBSA/PEG core-sheath nanoﬁbers (PCL-r-ﬁtcBSA/PEG denotes the core ﬁtcBSA/
PEG is wrapped inside the PCL sheath); (b) TEM image of coaxially electrospun PCL-r-ﬁtcBSA/PEG nanoﬁber [71].
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polyester aminolysis followed by Fn coupling via glutaldehyde.
Porcine esophageal epithelial cells were seeded on the Fn bonded
scaffold to test the cell growth promotion against the control
unmodiﬁed PLLC nanoﬁber scaffold using tissue culture poly-
styrene plate as reference. Fn grafted on PLLC scaffold greatly
promotes epithelium regeneration and is expected a good candi-
date for functional esophagus substitutes.
Wang et al. [78] have shown improved catalytic efﬁciency of
immobilized enzymes in bioactive electrospun membranes. Bioac-
tive polystyrene nanoﬁbers with a typical diameter of 120 nmwere
prepared by electrospinning of functionalized PS followed by
chemical attachment of a model enzyme, a-chymotrypsin and
examined for catalytic efﬁciency for biotransformations (Scheme 2).
Nanoﬁbrous a-chymotrypsin exhibited over 3 orders of magnitudeFig. 11. Characteristic ﬂuorescent micrographs showing the variation in ﬁber diameter
that results from cell encapsulations. Experiments were conducted at an applied
voltage of 9.5 kV under ﬂow rate conditions E6 (A) and A2 (B) [72].higher non-aqueous activity than that of its native counterpart
suspended in organic solvents.
Biodegradable synthetic matrices that resemble the size, scale,
architecture and mechanical properties of the native extra cellular
matrix (ECM) can be fabricated through electrospinning. Tubular
conduits may also be fabricated with properties appropriate for
vascular tissue engineering. Achieving substantial cellular inﬁltration
within the electrospun matrix in vitro remains time consuming and
challenging. This difﬁculty was overcome by electrospraying smooth
muscle cells (SMCs) concurrently with electrospinning of a biodeg-
radable, elastomericpoly(ester urethane) urea (PEUU) small-diameter
conduit [79]. Hematoxylin and eosin (H&E) staining demonstrated
qualitatively uniform SMCs integration radially and circumferentially
within the conduit after initial static culture. Conduitswere strongand
ﬂexible with mechanical behaviors that mimicked those of native
arteries, including static compliance of 1.6 0.5103 mmHg1,
dynamic compliance of 8.71.8 104 mmHg1, burst strengths of
1750 220 mmHg, and suture retention. This method to rapidly and
efﬁciently integrate cells into a strong, compliant biodegradable
tubular matrix represents a signiﬁcant achievement as a tissue engi-
neering approach for blood vessel replacement.7. Modiﬁed electrospinning processes for biomedical
applications
Electrospinning procedure is further modiﬁed to accommodate
needs of materials for biomedical applications. Dual syringe reac-
tive electrospinning is one of such modiﬁcations (Fig. 14) [80].
A facile fabrication of cross-linked hyaluronic acid hydrogel
nanoﬁbers for tissue engineering by a reactive electrospinning
method is described by Ji et al. [80]. A thiolated HA derivative, 3,30-
dithiobis(propanoic dihydrazide)-modiﬁed HA (HA–DTPH), and
poly(ethyleneglycol) diacrylate (PEGDA) are selected as the cross-
linking system (Scheme 3). The cross-linking reaction occurs
simultaneously during the electrospinning process using a dual-
syringe mixing technique. A cell morphology study on ﬁbronectin
(Fn) adsorbed HA nanoﬁbers scaffolds shows that the NIH3T3
ﬁbroblasts migrate into the scaffold through the nanoﬁbrous
network, and demonstrate an elaborate three-dimensional
dendritic morphology within the scaffold.
Fig. 12. SEM image of composite ﬁbers consisting of PEO and M. luteus (a) and optical ﬂuorescence microscopy of electrospun PEO ﬁbers containing M. luteus functionalized by
a ﬂuorescent dye under normal illumination (b) and under UV illumination (c).
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besides controlling cell orientation and tissue growth. For example,
many musculoskeletal tissues exhibit signiﬁcant anisotropic
mechanical properties which shows highly oriented underneath
extra cellular matrix [81]. Latest developments in the ﬁeld of
electrospinning have made it possible to generate nanoﬁbers based
scaffolds with controlled ﬁber orientations [82]. A good reference to
this aspect is a review article byMurugan et al. [83]. Ayres et al. [84]
have shown how incremental changes in ﬁber alignment modulate
the material properties of a model scaffold taking gelatin as an
example. Nanoﬁber of poly(L-lactide-co-caprolactone) (75:25)
having diameters around 500 nmwith aligned topology mimicking
the circumferential orientation of cells and ﬁbrils found in the
medial layer of a native artery were produced by Xu et al. [85] This
scaffold showed to have a very favourable interaction with human
coronary artery smooth muscle cells (SMCs). SMCs migrated along
the axis of the aligned nanoﬁbers and expressed a spindle like
contractile phenotype. The adhesion and proliferation rate of SMCs
on the aligned nanoﬁbrous scaffold was shown to be more in
comparison to the plane polymer ﬁlms. Fibrous membranes of
aligned poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) ﬁbers
have been made through electrospinning [86]. A high drumFig. 13. A comparison of cells (human dermal ﬁbroblasts) in growth behaviour on different
pure PCL; (c) PCL with surface roughly collagen coated; and (d) pure collagen nanoﬁbers [7rotating speed of 3000 rpm could lead to a nearly perfect alignment
of PHBV ﬁbers during electrospinning. Huber et al. [87] have pro-
jected the problem of mechanical destabilisation of the spontane-
ously contractile neo tissues, resulting in the complete loss of
differentiating myotubes. They have therefore, tried to use parallel
aligned nylon 6/6 arrays for the culture of C2C12 myoblasts and
their differentiation to form mechanically stable, oriented myo-
tubes in vitro. The myogeneic potential of these cells was shown
not impaired and resulted in the formation of elongated myotubes
expressing alpha-actinin, adult myosin heavy chain and nicotinic
acetylcholine receptors as muscle speciﬁc marker proteins. Newly
formed C2C12 myotubes were oriented in parallel to the direction
of the underlying ﬁbrous substratum and exhibited a high level of
structural integration with the surrounding cells. In contrast, non-
woven, non-oriented nylon 6/6 meshes, produced by conventional
electrospinning, exhibited greatly reduced levels of C2C12 myo-
bolast attachment and adherent myoblasts did not differentiate
into myotubes.
The fabrication of alligned collagen nanoﬁbrous scaffolds is
described by Zhong et al. [88]. The electrospinning apparatus used
by them is shown in Fig. 15. The structure and in vitro properties of
these scaffolds were compared with a random collagen scaffold.nanoﬁbrous scaffolds: (a) individually collagen-coated PCL (core–shell) (Col-r-PCL); (b)
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Scheme 2. Chemical route for synthesis of functionalised polystyrene and subsequent attachment of enzyme [78].
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aligned scaffold exhibited lower cell adhesion but higher cell
proliferation.
Kim et al. [89] havemade a 3D nanoﬁbrous ﬁbroin scaffold (NFS)
with very high porosity (94%) and examined its feasibility in bone
regeneration and showed its superior performance over a 2-D
scaffold. A modiﬁed electrospinning method has been used. As-
spun nanoﬁbers are collected in a coagulation bath and formed in
a dispersed state. The dispersion is solidiﬁed by freeze drying,
resulting in a sponge like 3D nanoﬁbrous structure. 3D NFS with
high porosity is shown superior to 2-D NFS in terms of both cell
adhesion and proliferation and could be promising candidate
scaffold for large bone defects. Highly porous 3D nanoﬁbrous
scaffold of PCL is made by electrospinning using auxillary electrode
and chemical blowing agent (BA) by Kim et al. [90]. The detailed
shape and geometry of the auxillary electrode are shown in Fig. 16.Fig. 14. Schematic illustration of the electrospinning setup and the procedure for the
fabrication of HA–DTPH nanoﬁbrous scaffolds [80].High porosity and optimally designed pore size provide structural
space for cell accommodation and migration and enable the
exchange of nutrients between the scaffold and environment. The
growth characteristic of human dermal ﬁbroblast cells cultured in
thewebs showed the good adhesionwith the blownweb relative to
a normal electrospun mat. The nanoﬁber web had good tensile
properties and high porosity compared to a typical electrospun
nanoﬁber scaffold.
Different ﬁber meshes were prepared by Neves et al. [91] from
PEO and PCL using various patterned collectors with speciﬁc
dimensions and designs with an aim to evaluate the resulting mesh
properties relevant to biomedical applications.
The published literature clearly shows an edge of electro-
spinning technique for tissue engineering over other conventional
methods in terms of its simplicity and providing high porosity,
variable ﬁber diameters and ﬁber textures combined with suitable
biocompatible and bioerodable materials. Electrospinning as-
sembly can be varied in different ways for combining materials
properties with different morphological structures for tissue
engineering. Cell–ﬁber interaction studies for tissue engineering
purposes are challenging. Due to the three-dimensional nature of
the matrix, there could be lack of nutrients and oxygen in the inner
core of the matrix that could lead to misleading results regarding
cell–ﬁber interactions. Inspite of these and other problems
although these scaffolds at present are far from being optimized for
the individual target tissue, there is no doubt that electrospun
scaffolds are going to capture major place in future for tissue
engineering.
A novel structure combining polymeric micro and nanoﬁbers in
the same construct for bone tissue engineering is provided by
Tuzlakoglu et al. [92]. Macro support is sometimes required by the
cells to grow. Though there are many promising materials and
studies for tissue engineering, they have a limitation for 3D appli-
cations due to their small pore size, smaller than a cellular diameter
and cannot allow cell migration within the structure. Furthermore,
the small size of the ﬁbers tends not to maximize the points of cell
attachment which is a negative effect on the expression of several
factors and on cell spreading and differentiation according to
Tuzlakoglu et al. [92]. They have developed a novel Starch based
scaffold with 70% porosity from a blend of starch/polycaprolactone
(SPCL) (30/70 wt%) by a ﬁber bonding process. Later electro-
spinning was used to obtain nanoﬁbers onto SPCL ﬁber mash
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like cell line and rat bone marrow stromal cells) viability and
alkaline phosphatase (ALP) activity for both cell types were found
to be higher in nano/micro combined scaffolds than in control
scaffolds based on ﬁber meshes without nanoﬁbers (Fig. 17).
8. Drug release and implants
Drug release and tissue engineering are closely related areas.
Sometimes release of therapeutic factors can increase the efﬁciency
of tissue engineering. Various nanostructured materials for appli-
cations in tissue engineering and in drug delivery have been
reviewed by Goldberg et al. [93]. Electrospun ﬁbermats provide the
advantage of increased drug release as compared to cast-ﬁlms due
to the increased surface area. Kanawung et al. [94A] have studied
the release of model drugs like diclofenac sodium (DS) andFig. 15. Fiber alignment during electrospinning [88].tetracycline hydrochloride (TH) from electrospun PCL and poly-
(vinyl alcohol) (PVA) ﬁber mats. The cumulative release of the
model drugs increased monotonically with increasing immersion
time and became practically constant at long immersion times. The
release of antibiotic tetracycline hydrochloride and mefoxin is also
studied using electrospun poly(lactic acid) PLA and poly(ethylene-
co-vinylacetate) [94B] and PLA, respectively [94C]. Release studies
of diclofenac sodium from electrospun poly(maleic anhydride-alt-
2-methoxyethyl vinylether) mats [95] and poly(caprolactone-D,L-
lactide) [96] are also known.
Electrospun PLGA-based micro and nanoﬁbers as implants for
the sustained delivery of anticancer drug (paclitaxel) to treat C6
glioma (brin tumor) in vitro has been developed by Xie et al. [97A].
The sustained release of drug with this system was achieved forFig. 16. Schematic illustration of the electrospinning setup with an auxiliary cylin-
drical electrode. The cylindrical electrode has a radius of 13 mm and is 0.45 mm
thick [90].
Fig. 17. Rat bone marrow cells seeded on nano and microﬁber combined scaffolds (A) and only microﬁbers scaffolds (B) after 14 days of culture [92].
Table 4
Some of the representative electrospun systems studied for drug-release
applications
Electrospun mat Drug Reference
Poly(caprolactone) PCL Diclofenac sodium [94A]
Tetracycline hydrochloride [94A]
Resveratrol [100]
Gentamycin Sulfate [100]
Biteral [104]
Poly(lactic acid) PLA tetracycline hydrochloride
and mefoxin
[94B,94C,100]
Poly(caprolactone-D,L-lactide) Diclofenac sodium [96]
Poly(vinyl alcohol) PVA Diclofenac sodium [94,97B]
Tetracycline hydrochloride [94A]
Sodium salicylate, naproxen,
indomethacin
[97B]
Poly(maleic anhydride-alt-2-
methoxyethyl vinylether)
Diclofenac sodium [95]
Poly(lactide–glycolide) (PLGA) Paclitaxel (anticancer) [97A]
Tetracycline hydrochloride [106]
Poly(ethylene-co-vinylacetate) tetracycline hydrochloride [94B]
Gelatin Centella asiatica-herbal
extract
[99B]
Cellulose acetate Vitamin A and E [99C]
S. Agarwal et al. / Polymer 49 (2008) 5603–56215616more than 60 days. Mats of PVA nanoﬁbers were developed as
carriers of drugs for transdermal drug-delivery system by Supaphol
et al. [97B]. Four types of non-steroidal anti-inﬂammatory drug
with varying water solubility, i.e. sodium salicylate, diclofenac
sodium, naproxen, and indomethacin were tried as model drugs.
Nie et al. [98] have also constructed a PLGA/HA composite
scaffold for delivery of BMP-2 plasmid DNA. This work was carried
out to improve one of the present methods of gene delivery using
DNA loaded chitosan particles. Poly(lactide-co-glycolide) (PLGA)/
hydroxyapatite (HA) composite scaffolds with different amounts of
HA (0–10 %) are fabricated by electrospinning and DNA is incor-
porated into the scaffold in 3 different ways, i.e. naked DNA,
encapsulation of DNA/chitosan nanoparticles into scaffolds after
ﬁber fabrication by dipping, and encapsulation of DNA/chitosan
nanoparticles into scaffolds by mixing with PLGA/HA solution
before ﬁber fabrication. In this study it was shown that the addition
of HA nanoparticles increased the release rate of DNA for both
naked and encapsulated DNA. Cell culture experiments with
human marrow stem cells (hMSCs) show that the scaffolds with
encapsulated DNA/chitosan nanoparticles have higher cell attach-
ment, higher cell viability and desirable transfection efﬁciency of
DNA. Table 4 gives a small summary of some of the representative
electrospun systems studied for drug-release applications.
A protein-loaded three-dimensional scaffold can be used for
protein delivery and bone tissue regeneration. The recombinant
human bone morphogenetic protein-2 (rhBMP-2) loaded poly-
(D,L-lactide-co-glycolide)/hydroxylapatite (PLGA/HAp) composite
ﬁbrous scaffold by electrospinning were fabricated by Nie et al.
[99A]. It was also shown that BMP-2 protein maintained its integ-
rity and natural conformations after electrospinning and scaffold
allowed sustained release of BMP-2 whose release rate can be
controlled with the amount of HAp. Cell culture experiments also
showed that the encapsulation of HAp could enhance cell attach-
ment to scaffolds and lower cytotoxicity.
Recently Supaphol et al. [99B] have shown the release charac-
teristic of Centella asiatica-herbal extract from electrospun gelatin
ﬁbers. Centella asiatica-herbal extract is widely known for its
traditional medical applications including its wound healing ability.
Vitamin-loaded electrospun cellulose acetate nanoﬁber mats as
transdermal and dermal therapeutic agents of vitamin A acid and
Vitamin E are made by Supaphol et al. [99C].
Weak electrolytes like poly(acrylic acid) (PAA) and poly(allyl-
amine hydrochloride) (PAH) were also electrospunwith methylene
blue as model drug to evaluate the electrospun ﬁbers for drug-
delivery applications [100]. Sustained release of the model drug
was achieved by using perﬂuorosilane networks on the ﬁber
surfaces as capping layers. The authors have also showed temper-
ature controlled release of model drug by depositing temperature
sensitive poly(N-isopropylacrylamide) (PNIPAAM) onto the
surfaces. The antibiotic (Biteral) embedded PCL membranes were
formed by electrospinning by Bolgen et al. [101] with an aim toprevent post surgery induced abdominal adhesions. The antibiotic
embedded PCL membranes were implanted on the abdominal wall
of rats and macroscopical and histological evaluations showed the
reduced extent, type, and tenacity of adhesion.
Further, Hu et al. [102] prepared composite ﬁbers with beads-in-
string structures via electrospinning from either W/O or O/W
emulsion and thus proved this technique (Fig. 18) as an effective
method for microencapsulation. To immobilize hydrophilic protein
in hydrophobic polymer, Ca-alginate microspheres were prepared
in W/O emulsion and served as drug reservoirs for bovine serum
albumin (BSA). After dissolving with poly(L-lactic acid) (PLLA) to its
continuous phase, the emulsion was spun into ﬁbers by the elec-
trospinning technique. In the in vitro release test, BSAwas retained
in composite ﬁbers for 120 h, in contrast to in naked microspheres,
which were almost completely released in the ﬁrst 10 h.
In general, the drug release proﬁle is dependent on how good
the drug is dispersed in the matrix polymer. In all the representa-
tive examples given above, the drugs are mixed (dissolved/
dispersed in the polymer solution before electrospinning). There is
always a probability of ﬁnding drug on nanostructured surfaces
besides being encapsulated inside thereby leading to burst release
in the initial stages.
An alternative method to encapsulate drugs, proteins, growth
factors, genes etc. inside polymeric nanoﬁbers is by coaxial
Fig. 18. SEM micrograph of electrospun ﬁbers by emulsion [102].
Fig. 19. Release of ﬁtcBSA from PPX-coated PVA/BSA nanoﬁbers which were immersed
in water at 37 C for different periods with different layers thickness of PPX [105].
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core–shell ultraﬁne ﬁber mats for drug-delivery application is
described by He et al. [103A]. PLA and tetracycline hydrochloride
were employed as shell and core materials, respectively. Their
results showed that a reservoir type drug release device can be
conveniently obtained through encapsulation. The electrospun
ultraﬁne ﬁber mats containing drugs may be used as drug release
carriers or made into biomedical devices such as sutures and
wound dressings. Huang et al. [103B] have encapsulated drugs like
Resveratrol (antioxidant) and Gentamycin Sulfate (an antibiotic) in
biodegradable poly(caprolactone) PCL ultraﬁne ﬁbers through
coaxial electrospinning. The release proﬁles of the two drugs
exhibited a sustained release characteristic, with no burst-release
phenomenon. Also, biodegradable core–shell structured ﬁbers with
poly(caprolactone) as shell and bovine serum albumin (BSA)-con-
taining dextran as core were prepared by Hongliang et al. [104] by
coaxial electrospinning technique for incorporation and controlled
release of proteins. Protein loading percent in the ﬁbers and its
release rate can easily be controlled by either the feed rate of the
inner dope during electrospinning or by making the shell more
hydrophilic. Coaxial electrospinning is shown to have the advan-
tages of being fast, high loading efﬁciency, and controllable release
behaviour over conventional methods of encapsulating proteins,
growth factors and DNA like water-in-oil-in-water emulsion, gas
foaming/particulate leaching methods. Zhang et al. [71] have
shown better sustainability of release of biomolecules from core–
shell ﬁbers of PCL and ﬁtcBSA/PEG ﬁbers. Burst-release effect could
be suppressed but could not be eliminated completely.
In our group [105] we have tried to control the burst-release
effect of biomolecules, a very common problem, from electrospun
reservoirs by providing an extra protective coating on the drug
reservoirs. The concept was shown using poly(vinyl alcohol) (PVA)
based protein delivery system. Protein-loaded (bovine serum
albumin (BSA) or luciferase) PVA nanoﬁbers were obtained
by electrospinning. Poly(p-xylylene) (PPX, also coined as parylene)
coated PVA/BSA nanoﬁbers were prepared by chemical vapor
deposition (CVD). The release of BSA from PVA nanoﬁbers
under physiological conditions was monitored by absorption
spectroscopy. Burst release of BSA was noted with uncoated PVA
nanoﬁbers. In contrast, PPX-coated nanoﬁbers exhibited a signiﬁ-
cantly retarded release of BSA depending on the coating thicknessof PPX (ranging from 40 to 300 nm) (Fig. 19). Luciferase was used
here as model enzyme, which after electrospinning retained its
enzyme activity. This preservation of enzyme activity and the
continuous release of the intact enzyme from the immersed ﬁbers
meet a fundamental prerequisite for the application of enzymes or
other sensitive agents released from electrospun nanoﬁbers.
Further, a modiﬁed electrospinning method has been provided
by Wagner et al. [106] for the creation of an elastomeric, ﬁbrous
sheet (ﬁbrous composite sheet with two distinct submicrometer
ﬁber populations: biodegradable poly(ester urethane) urea (PEUU)
and poly(lactide-co-glycolide) (PLGA)), where the PLGAwas loaded
with the antibiotic tetracycline hydrochloride (PLGA–tet) capable of
sustained antibacterial activity in vitro. Composite sheets were
ﬂexible with breaking strains exceeding 200%, tensile strengths of
5–7 MPa, and high suture retention capacity. The blending of PEUU
ﬁbers markedly reduced the shrinkage ratio observed for PLGA–tet
sheets in buffer from 50% to 15%, while imparting elastomeric
properties to the composites. In development of this material,
a new approach to two-stream electrospinning (Fig. 20) was used
wherein one component stream provided for antibiotic release
while the other provided mechanical properties deemed essential
for the desired application. This material may ﬁnd applicability in
the treatment of temporary abdominal wall closure.
9. Wound dressing
Electrospinning could generate scaffold withmore homogeneity
besides meeting other requirements like oxygen permeation and
protection of wound from infection and dehydration for use as
wound-dressing materials. The conventional skin substitutes are
made up of ﬁbroblasts and/or keratinocytes on collagen scaffolds,
mainly generated by freeze drying (FD) which generates structural
heterogeneity. ES could provide wound-dressing materials in
a simple way. Powell et al. [107] have compared FD and ES skin
substitutes based on natural polymer, collagen. They are compared
for cell distribution, proliferation, organization, and maturation
engraftment and healing of full thickness wounds in a thymic mice.
Although no signiﬁcant difference in cell proliferation, surface
hydration or cellular organization between FD and ES scaffolds
were seen, wound contraction was potentially reduced with ES
scaffold. This provides the advantage of reduced morbidity in
patients treated with skin substitutes from ES collagen. Many other
synthetic and natural polymers like carboxyethyl chitosan/PVA [19],
collagen/chitosan [108], Silk ﬁbroin [3], ABA type poly(dioxanone-
co-L-lactide)-block-poly(ethylene glycol) (PPDO/PLLA-b-PEG) block
Fig. 20. Two-stream electrospinning setup [106].
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wound-dressing applications.
Further, wound-dressing material was prepared by electro-
spinning of (PVA)/AgNO3 aqueous solution into non-woven webs
and then treating the webs by heat or UV radiation [110]. Through
SEM, TEM, and XPS analyses, it was observed that the silver (Ag)
nanoparticles were generated and existed in the near surface of the
electrospun nanoﬁbers (Fig. 21). Heat treatment as well as UV
radiation reduced the Ag ions in the electrospun PVA/AgNO3 ﬁber
web into the Ag nanoparticles. Also the heat treatment improved
the crystallinity of the electrospun PVA ﬁber web and so it made
the web insoluble in moisture environment. As we know, silver has
long been recognized as a broad-spectrum and highly effective
antimicrobial agent for treating wounds and burns. Silver ionworksFig. 21. TEM image of post-UV treated electrospun PVA/AgNO3 ﬁber web [110].by denaturating the proteins and nucleic acids of the bacteria by
binding to their negatively charged components. Besides, silver acts
in generating oxygen which in turn destroys the cell wall
membranes of bacteria [111]. As pointed out by Hong et al. [110]
metallic silver is also used commercially in wound dressings such
as Acticoat (Smith & Nephew Health), in which silver is applied to
the polymer mesh by a vapor deposition process. It surely shows an
excellent antibacterial activity above 99.9%. However, there are
some demerits; for instance, the metallic silver of the wound
dressing leads to gray-blue discoloration on the skin and moisture
supplies are regularly necessary to dissolve the metallic silver and
also the manufacturing cost is nevertheless relatively high. There-
fore, the electrospun PVA/AgNO3 ﬁber webs prepared are prom-
ising materials as wound dressings.
Duan et al. [111] have also produced antimicrobial nanoﬁbers of
poly(3-caprolactone) (PCL) by electrospinning of a PCL solution
with small amounts of silver-loaded zirconium phosphate nano-
particles (nano AgZr) for potential use in wound-dressing appli-
cations. The results of the antimicrobial tests showed that these
ﬁbers have maintained the strong killing abilities of Ag existed in
the nano AgZr against the tested bacteria strains (Gram-positive
Staphylococcus aureus (ATCC 6538) and Gram-negative E. coli (ATCC
25922)). Discoloration has not been observed in the nanoﬁbers. To
test the biocompatibility of nanoﬁbers as potential wound dress-
ings, primary human dermal ﬁbroblasts (HDFs) were cultured on
the nanoﬁbrous mats. The cultured cells were evaluated in terms of
cell proliferation and morphology. The results indicated that the
cells attached and proliferated as continuous layers on the nano
AgZr-containing nanoﬁbers and maintained the healthy
morphology of HDFs. Electrospinning of poly(vinyl pyrrolidone)–
iodine complex and poly(ethylene oxide)/poly(vinyl pyrrolidone)–
iodine complex as prospective route to antimicrobial wound
dressing materials was also shown by Ignatova et al. [112].
Effects on the early stage wound healing of poly (3-hydroxy-
butyrate-co-3-hydroxyvalerate) (PHBV) nanoﬁber matrices
cultured with hair follicular cells were tested by Han et al. [113].
PHBV only, PHBV/Colagen and PHBV/gelatin at a 7:3 weight ratio
were produced by electrospinning. Their in vitro cell culture and in
vivo wound healing as biological dressings were also examined. In
Fig. 22. Electrospun Hemoglobin and myoglobin mats using 2,2,3-triﬂuoroethanol solvent [115B].
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attached to hydrophilic PHBV/collagen and PHBV/ gelatin faster
than hydrophobic PHBV. Also if cocultured for 3–5 days with DS
and epithelial outer root sheath (ORS) cells expressed more extra
cellular materials, such as type I collagen, elastin and alpha smooth
muscle actin. In vitro culture studies of human dermal ﬁbroblasts
on electrospun PCL collagen blend nanoﬁbrous membranes are
shown to be promising for dermal substitute for the treatment of
skin defects and burn wounds by Ramakrishna et al. [114]. Also,
Barnes et al. [115A] have provided an overview of tissue engi-
neering via electrospun biomimetic nanoﬁbers and also electro-
spun hemoglobin and myoglobin [115B] with an aim that their
inclusion in wound dressings may help in delivering oxygen
directly to the healing tissues (Fig. 22).
Further, Kim et al. [116] have introduced a direct-electro-
spinning apparatus that uses a guiding electrode and an air-
blowing system to enable the fabrication of wound-dressing
membranes of PCL micro/nano ﬁbers. Stable, steady deposition of
electrospun ﬁbers on any substrate occurred without interrupting
the charges on the substrate with sufﬁcient removal of solvent. The
guiding electrode was used to eliminate static charges in the elc-
trospun ﬁbers (Fig. 23).
10. Miscellaneous
Polymeric electrospun nanoﬁber web-based artiﬁcial renal micro-
ﬂuidic chip was developed by Lee et al. [117]. They have produced poly-
ethersulfoneandpolyurethanebasednanoﬁberwebsbyelectrospinning
and combined this with the poly(dimethylsiloxane) (PDMS) based
microﬂuidic platform top create a chip-based portable hemodialysis
system. The ﬁltration capability of this dialyzing chipwasmeasured
for molecules in broad ranges of sizes. Blood cells were not
mechanically affected during the ﬁltration and their transportation
through chip. This demonstrated the feasibility of chip-based
hemodialysis realization of portable hemodialysis systems.
The nanoﬁber deposition method, by electrospinning, was
employed to introduce antibacterial activity and biocompatibility to
the surface of poly(ethylene terephthalate) (PET) textiles [118]. The
polymer blends of PET and chitosan were electrospun on the PET
micro-non-woven mats for biomedical applications. Antobactetial
activity is reported against S. aureus and Klebsiella pneumoniae.Fig. 23. Schematic illustration of the wound dresser using an electrospinning process,
that includes supporting electrodes (a conical electrode and guiding electrodes) and an
air-streaming system [116].11. Conclusions
The important advantages of electrospinning technique are the
production of very thin ﬁbers with large surface areas, ease of
functionalisation for various purposes, superior mechanical prop-
erties and ease of process. These advantages provide a wide range
of opportunities for their use in many different biomedical appli-
cations. These applications range from tissue engineering, drug
release, implants, biotransformations to wound healing. Electro-
spinning assembly can be varied in different ways for combining
materials properties with different morphological structures for
these applications. Also, although there is ever increasing literature
on use of electrospinning for various biomedical applications but
still the ﬁeld is in its infancy. Although a series of new and
commercially available polymers have been proposed as matrices
for cell regeneration and proliferation for tissue engineering
applications but lot of questions like interaction of scaffolds with
biological systems, toxicity, in vivo studies etc. have to be thor-
oughly investigated before the technology can be used for any real
practical biomedical application.
Drug release and tissue engineering are closely related areas.
Large number of biodegradable and biocompatible polymers have
also been electrospun by conventional electrospinning or modiﬁed
electrospinning methods like co-axial electrospinning etc. loaded
with different drugs as model studies. These studies show the
advantages of electrospinning technique for example in reducing
the burst release of drugs in vitro. There are only few studies which
have been really carried out in animals in vivo. There is a need for
making joint efforts by material scientists and biologists to make
serious in vivo drug release studies under physiological conditions.
This is the time to transfer laboratory research on use of electro-
spinning for biomedical applications to clinical use. There is no
doubt that electrospun materials are going to take major place in
future for biomedical applications, but methods and materials have
to be provided which can be used on a technical scale as well.References
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